Spyre Therapeutics Inc (SYRE)

Cash & Short-Term Investments

$1.15B

Quarterly · Period ending: · USD

SYRE logo

SYRE Cash & Short-Term Investments

Latest reported$1.15B
SYRE Quarterly Cash & Short-Term Investments ($2.62M → $1.15B)
High-resolution chart · PNG

SYRE cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
1,145,346,000
741,467,000
756,533,000
486,198,000
526,580,000
564,820,000
603,088,000
414,227,000
425,995,000
484,641,000
339,277,000
203,599,000
235,358,000
38,478,000
55,711,000
73,676,000
88,550,000
66,725,000
93,128,000
112,428,000
128,578,000
126,660,000
146,273,000
139,976,000
157,730,000
48,992,000
71,949,000
88,700,000
105,541,000
123,715,000
74,513,000
64,735,000
72,193,000
43,475,000
50,299,000
55,749,000
63,393,000
57,868,000
63,502,000
68,035,000
73,575,000
28,986,000
33,062,000
34,142,000
39,081,000
43,791,000
2,616,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.